Kisqali — Medical Mutual
Other indication cited in NCCN guidelines as a category 1, 2A, or 2B recommendation
Initial criteria
- Prescriber will provide specific diagnosis for documentation
Reauthorization criteria
- Prescriber will provide evidence of beneficial response warranting continuation of therapy
Approval duration
initial 6 months; reauth 1 year